Instead of “running with the herd” to develop therapeutics that treat the advanced stages and symptoms of autoimmune and inflammatory diseases after they’ve emerged, Provention Bio is taking a path less travelled, by pre-empting, slowing and reversing the progression of chronic diseases and developing technologies that intervene before the targeted disease begins, re-appears or progresses.
Provention Bio, Inc. is a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics and cutting edge solutions to intercept and prevent immune-mediated disease.more about provention bio >
Provention Bio’s strategy is to develop and commercialize novel agents, therapeutics and cutting edge solutions to intercept and prevent immune-mediated disease. We foresee substantial opportunity to pre-empt, slow and reverse the progression of a variety of chronic immune-mediated and inflammatory diseases by identifying and targeting at-risk individuals, focusing on potential pre-disease states, and developing “upstream” mechanisms of action.more therapeutic mission >
For more information: call 908.336.0360 or email: firstname.lastname@example.org